We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
With a Zacks Rank #5 (Strong Sell), Goosehead Insurance (GSHD - Free Report) stock is flagged as the Bear of the Day again this year after landing this mark in late January. Since then, GSHD is down 20% as I previously mentioned how the California Wildfires could affect Goosehead Insurance more than other insurance companies due to its weaker balance sheet.
However, even at $84 a share as opposed to a 52-week high of $130, Goosehead Insurance stock still appears to have more downside risk ahead and looks overvalued amid rising costs and increased competition.
Image Source: Zacks Investment Research
Goosehead's Operating Expenses Jump 25%
Reporting its Q2 results last Wednesday, Goosehead Insurance’s operating expenses jumped 25% year over year to $78.4 million from $62.7 million in the prior period.
Notably, Goosehead is prioritizing long-term growth for short-term profitability, which can spook investors with Q2 EPS of $0.49 missing expectations of $0.53 despite sales of $94.03 million topping estimates of $93.91 million.
This comes as the company is planning to boost its tech investments in AI and expand its franchise, but was hit with impairment charges for existing underperforming leases.
The real elephant in the room is that although Goosehead Insurance still has relatively promising growth prospects after going public in 2018, GSHD trades at a stretched 47.5X forward earnings multiple compared to its Zacks Insurance-Multi line Industry average of 9.8X.
Holding less than 1% of the market share as it relates to the U.S. personal lines market, Goosehead is vulnerable to larger industry players like American International Group (AIG - Free Report) and Prudential Financial (PRU - Free Report) , which trade at much more reasonable valuations. On the other end of the spectrum, Goosehead is being pulled into an AI arms race from emerging rivals like Lemonade Inc. (LMND - Free Report) and Oscar Health (OSCR - Free Report) that are also aiming to challenge traditional insurance brokers.
It's noteworthy that in terms of a more formidable valuation metric for up-and-coming companies, such as price to sales, Goosehead Insurance also trades at a stretched forward P/S ratio of 9X compared to the industry average of 1.5X.
Image Source: Zacks Investment Research
Goosehead's Insolvency Problem
More concerning is that at the end of Q2, Goosehead Insurance's balance sheet revealed that the company now meets the criteria for potentially being insolvent. In this regard, Goosehead has $567 million in total liabilities, which is unpleasantly above its total assets of $437 million.
Image Source: Zacks Investment Research
Bottom Line
One of the general rules of thumb when investing in stocks is to avoid insolvent companies, especially if it’s not a “cheap” penny stock under $5 a share or less. Unfortunately, Goosehead Insurance stock has checked this red flag and is experiencing a decline in EPS revisions for fiscal 2025 and FY26 following the Q2 earnings miss, which correlates with its Zacks Rank #5 (Strong Sell) rating.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bear of the Day: Goosehead Insurance (GSHD)
With a Zacks Rank #5 (Strong Sell), Goosehead Insurance (GSHD - Free Report) stock is flagged as the Bear of the Day again this year after landing this mark in late January. Since then, GSHD is down 20% as I previously mentioned how the California Wildfires could affect Goosehead Insurance more than other insurance companies due to its weaker balance sheet.
However, even at $84 a share as opposed to a 52-week high of $130, Goosehead Insurance stock still appears to have more downside risk ahead and looks overvalued amid rising costs and increased competition.
Image Source: Zacks Investment Research
Goosehead's Operating Expenses Jump 25%
Reporting its Q2 results last Wednesday, Goosehead Insurance’s operating expenses jumped 25% year over year to $78.4 million from $62.7 million in the prior period.
Notably, Goosehead is prioritizing long-term growth for short-term profitability, which can spook investors with Q2 EPS of $0.49 missing expectations of $0.53 despite sales of $94.03 million topping estimates of $93.91 million.
This comes as the company is planning to boost its tech investments in AI and expand its franchise, but was hit with impairment charges for existing underperforming leases.
Goosehead’s Stretched Valuaiton & Increased Competition
The real elephant in the room is that although Goosehead Insurance still has relatively promising growth prospects after going public in 2018, GSHD trades at a stretched 47.5X forward earnings multiple compared to its Zacks Insurance-Multi line Industry average of 9.8X.
Holding less than 1% of the market share as it relates to the U.S. personal lines market, Goosehead is vulnerable to larger industry players like American International Group (AIG - Free Report) and Prudential Financial (PRU - Free Report) , which trade at much more reasonable valuations. On the other end of the spectrum, Goosehead is being pulled into an AI arms race from emerging rivals like Lemonade Inc. (LMND - Free Report) and Oscar Health (OSCR - Free Report) that are also aiming to challenge traditional insurance brokers.
It's noteworthy that in terms of a more formidable valuation metric for up-and-coming companies, such as price to sales, Goosehead Insurance also trades at a stretched forward P/S ratio of 9X compared to the industry average of 1.5X.
Image Source: Zacks Investment Research
Goosehead's Insolvency Problem
More concerning is that at the end of Q2, Goosehead Insurance's balance sheet revealed that the company now meets the criteria for potentially being insolvent. In this regard, Goosehead has $567 million in total liabilities, which is unpleasantly above its total assets of $437 million.
Image Source: Zacks Investment Research
Bottom Line
One of the general rules of thumb when investing in stocks is to avoid insolvent companies, especially if it’s not a “cheap” penny stock under $5 a share or less. Unfortunately, Goosehead Insurance stock has checked this red flag and is experiencing a decline in EPS revisions for fiscal 2025 and FY26 following the Q2 earnings miss, which correlates with its Zacks Rank #5 (Strong Sell) rating.